Since classical HLA class I molecules are recognized by tumor-specific cytotoxic CD8+ T lymphocytes, the downregulation or loss of HLA class I molecules will enable tumors to escape from T-cell-mediated immune responses [128]. This evidence concerns the gene CD8A and neoplasm.